Immunoglobulin replacement therapy by self-infusion at home.
Twelve patients, ten with common variable hypogammaglobulinaemia and two with hypogammaglobulinaemia secondary to chronic lymphocytic leukaemia (CLL), have been taught to self-infuse their intravenous immunoglobulin replacement therapy. Follow-up of these patients has shown that regular self-infusio...
Main Authors: | , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1988
|
_version_ | 1797105006280704000 |
---|---|
author | Chapel, H Brennan, V Delson, E |
author_facet | Chapel, H Brennan, V Delson, E |
author_sort | Chapel, H |
collection | OXFORD |
description | Twelve patients, ten with common variable hypogammaglobulinaemia and two with hypogammaglobulinaemia secondary to chronic lymphocytic leukaemia (CLL), have been taught to self-infuse their intravenous immunoglobulin replacement therapy. Follow-up of these patients has shown that regular self-infusion at home is feasible and safe. There have been no anaphylactic or other serious reactions. Excellent patient compliance results from greater convenience and control over their own lives, in addition to time and money saved by the hospital. |
first_indexed | 2024-03-07T06:41:22Z |
format | Journal article |
id | oxford-uuid:f96595f7-7305-40e1-95d8-38590e2ca492 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T06:41:22Z |
publishDate | 1988 |
record_format | dspace |
spelling | oxford-uuid:f96595f7-7305-40e1-95d8-38590e2ca4922022-03-27T12:57:38ZImmunoglobulin replacement therapy by self-infusion at home.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f96595f7-7305-40e1-95d8-38590e2ca492EnglishSymplectic Elements at Oxford1988Chapel, HBrennan, VDelson, ETwelve patients, ten with common variable hypogammaglobulinaemia and two with hypogammaglobulinaemia secondary to chronic lymphocytic leukaemia (CLL), have been taught to self-infuse their intravenous immunoglobulin replacement therapy. Follow-up of these patients has shown that regular self-infusion at home is feasible and safe. There have been no anaphylactic or other serious reactions. Excellent patient compliance results from greater convenience and control over their own lives, in addition to time and money saved by the hospital. |
spellingShingle | Chapel, H Brennan, V Delson, E Immunoglobulin replacement therapy by self-infusion at home. |
title | Immunoglobulin replacement therapy by self-infusion at home. |
title_full | Immunoglobulin replacement therapy by self-infusion at home. |
title_fullStr | Immunoglobulin replacement therapy by self-infusion at home. |
title_full_unstemmed | Immunoglobulin replacement therapy by self-infusion at home. |
title_short | Immunoglobulin replacement therapy by self-infusion at home. |
title_sort | immunoglobulin replacement therapy by self infusion at home |
work_keys_str_mv | AT chapelh immunoglobulinreplacementtherapybyselfinfusionathome AT brennanv immunoglobulinreplacementtherapybyselfinfusionathome AT delsone immunoglobulinreplacementtherapybyselfinfusionathome |